Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

NA

Levocetirizine impurity N-Oxide

NA
NA

Levocetirizine Impurity Lactose Ester

NA
165800-03-3

Linezolid

165800-03-3
84057-84-1

Lamotrigin

84057-84-1
16595-80-5

Levamisole HCl

16595-80-5
137-58-6

Lidocain

137-58-6
7179-49-9

Lincomycin HCl H2O

7179-49-9
848-75-9

Lormetazepam

848-75-9
578-86-9

Liquiritigenin

578-86-9
1256388-51-8

Ledipasvir

1256388-51-8
NA

Lincomycin D3

NA
98079-52-8

Lomefloxacin HCl

98079-52-8
859-18-7

Lincomycin HCl

859-18-7
25999-20-6

Lasalocid A Sodium salt

25999-20-6
79547-78-7

Levocabastine HCl

79547-78-7
114798-26-4

Losartan

114798-26-4
99291-25-5

Levodropropizine EP

99291-25-5
84057-84-1

Lamotrigine EP

84057-84-1
134678-17-4

Lamivudine

134678-17-4
127-40-2

Lutein

127-40-2